Elevated levels of soluble CD8 molecule in patients with lymphatic filariasis

Immunol Lett. 1990 Oct;26(1):85-8. doi: 10.1016/0165-2478(90)90180-x.

Abstract

The serum levels of soluble forms of suppressor/cytotoxic cells (sCD8) and interleukin-2 receptor (sCD25) were analyzed in 67 patients with lymphatic filariasis and 28 normal controls. Our results show that patients with lymphatic filariasis have significantly higher levels of sCD8 (p less than 0.05) than the control groups, whereas no such difference was observed for sCD25. Within the patient group, however, those in the chronic lymphatic obstruction (CP) had significantly higher levels of both sCD8 (491 +/- 52 U/ml, p less than 0.001) and sCD25 (293 +/- 36 U/ml; p less than 0.02) than those with asymptomatic microfilaremia (sCD8 344 +/- 32 U/ml; sCD25 190 +/- 10 U/ml, respectively). No statistically significant correlation was observed between the serological levels of sCD8 and the percentage of CD8 on peripheral blood T lymphocytes in any of the patient groups. Evaluation of the activation state of B lymphocyte did not reveal any difference in the cellular expression of B7, or serum levels of soluble CD23 in any of the groups studied. Thus the selective increase of sCD8 in patients with filariasis suggests a possible pathogenic role of the cells involved in the release of this molecule.

MeSH terms

  • Antibodies, Monoclonal
  • Antigens, Differentiation, B-Lymphocyte / blood
  • Antigens, Differentiation, T-Lymphocyte / blood*
  • Antigens, Surface / immunology
  • B-Lymphocytes / immunology
  • CD8 Antigens
  • Elephantiasis, Filarial / immunology*
  • Humans
  • Immunophenotyping
  • Lymphocyte Subsets / immunology
  • Receptors, Fc / blood
  • Receptors, IgE
  • Receptors, Interleukin-2 / blood

Substances

  • Antibodies, Monoclonal
  • Antigens, Differentiation, B-Lymphocyte
  • Antigens, Differentiation, T-Lymphocyte
  • Antigens, Surface
  • CD8 Antigens
  • Receptors, Fc
  • Receptors, IgE
  • Receptors, Interleukin-2